CD274 and neoplasm: PD-L1 plays a dominant role in suppressing in vivo effector T-cell responses, especially in the tumor microenvironment, and PD-L1 expression in this microenvironment is thought to be regulated by tumor-associated stroma (adaptive immune resistance) and/or tumor cells (intrinsic immune resistance) [14, 36].